अApnaFunda
Menu

ACUTAAS CHEMICALS LIMITED (ACUTAAS)

Process Industries · Chemicals: Specialty · figures to Nov '26

Momentum #10Quality #17Balance sheet #3Overall #2
Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.97 / 100
Profitability 97Growth 95Balance sheet 100
Momentum scoreHow strong the recent trend is: 3-month price change, 12-month improvement in earnings and the rise in FII + DII holding, among companies above ₹500 cr.90 / 100
Price 90Earnings 93FII/DII 87

Passes these screensQuality CompounderHigh MomentumDebt-light & profitableConsistent compoundersNear 52-week high

Compare withLINDE INDIACOROMANDEL INTERNATIONAL LIMITGUJARAT FLUOROCHEMICALS

Share price

Closing priceAdjusted for splits and bonus issues.

₹3,882.6 latest close · +5.1% over the last 90 sessions

₹3,000₹3,500₹4,000Jul 3Jul 29Aug 24Sep 17Oct 14Nov 9 ₹3,000₹3,500₹4,000Jul 3Sep 4Nov 9

₹3,882.6 month-end · +111.3% over 12 months

₹2,000₹3,000₹4,000Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26 ₹2,000₹3,000₹4,000Nov '25May '26Nov '26

₹3,882.6 month-end · +597.8% over 3 years

₹2,000₹4,000Nov '23Jun '24Jan '25Sep '25Apr '26Nov '26 ₹2,000₹4,000Nov '23May '25Nov '26

₹3,882.6 month-end · +505.3% since Sep '21

₹2,000₹4,000Sep '21Sep '22Oct '23Oct '24Nov '25Nov '26 ₹2,000₹4,000Sep '21Apr '24Nov '26

52-week range ₹1570.00 to ₹4045.30 · 1-year volatility 47.1%

Was the rally earned?

+111%share price, 1 yearEarnings-driven

Mostly yes.

  • Per-share earnings added 106 points to the rise, while the multiple moved less (P/E 79.6x to 82.3x).
  • The share count barely moved.
Net profit growth: +106 pts. Points of the price return explained by net profit growing (or shrinking).+106 ptsNet profit growthP/E change: +5 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+5 ptsP/E changeShare count change: +1 pts. Points of the price return explained by the share count changing. More shares count against the price.+1 ptsShare count changeShare price: +111%+111%Share priceNet profit growth: +106 pts. Points of the price return explained by net profit growing (or shrinking).+106ProfitP/E change: +5 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+5P/EShare count change: +1 pts. Points of the price return explained by the share count changing. More shares count against the price.+1SharesShare price: +111%+111%Share price
Net profit growth+106 ptsNet profit rose about 103%, which lifts the price.
P/E change+5 ptsThe P/E rose from 79.6x to 82.3x, which lifts the price.
Share count change+1 ptsShare count was little changed. More shares would count against the price.
+598%share price, 3 yearsEarnings-driven

Mostly yes.

  • Per-share earnings added 436 points to the rise, while the multiple moved less (P/E 48.7x to 82.3x).
  • The share count rose 13%.
Net profit growth: +473 pts. Points of the price return explained by net profit growing (or shrinking).+473 ptsNet profit growthP/E change: +162 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+162 ptsP/E changeShare count change: −37 pts. Points of the price return explained by the share count changing. More shares count against the price.−37 ptsShare count changeShare price: +598%+598%Share priceNet profit growth: +473 pts. Points of the price return explained by net profit growing (or shrinking).+473ProfitP/E change: +162 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+162P/EShare count change: −37 pts. Points of the price return explained by the share count changing. More shares count against the price.−37SharesShare price: +598%+598%Share price
Net profit growth+473 ptsNet profit rose about 365%, which lifts the price.
P/E change+162 ptsThe P/E rose from 48.7x to 82.3x, which lifts the price.
Share count change-37 ptsShare count rose 13%, which lowers the price.
+761%share price, 5 yearsEarnings-driven

Mostly yes.

  • Per-share earnings added 603 points to the rise, while the multiple moved less (P/E 52.6x to 82.3x).
  • The share count rose 30%.
Net profit growth: +695 pts. Points of the price return explained by net profit growing (or shrinking).+695 ptsNet profit growthP/E change: +158 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+158 ptsP/E changeShare count change: −92 pts. Points of the price return explained by the share count changing. More shares count against the price.−92 ptsShare count changeShare price: +761%+761%Share priceNet profit growth: +695 pts. Points of the price return explained by net profit growing (or shrinking).+695ProfitP/E change: +158 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+158P/EShare count change: −92 pts. Points of the price return explained by the share count changing. More shares count against the price.−92SharesShare price: +761%+761%Share price
Net profit growth+695 ptsNet profit rose about 615%, which lifts the price.
P/E change+158 ptsThe P/E rose from 52.6x to 82.3x, which lifts the price.
Share count change-92 ptsShare count rose 30%, which lowers the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with LINDE INDIA

How rough has the ride been?

Maximum drawdown-42.2%recovered 2024-07
1-year volatility47.1%annualised
Beta vs sector index1.063-year daily, correlation 0.40
Volume spikes3last 90 sessions, 5x the 50-day median

Drawdown from peak

0%−20%−40%20222023202420252026−39.1% 0%−20%−40%202220242026−39.1%
Largest drawdowns

-42.2% (2021-10 peak to 2022-02 low, recovered 2024-07)

-19.6% (2025-01 peak to 2025-01 low, recovered 2025-01)

-18.8% (2025-02 peak to 2025-04 low, recovered 2025-07)

Most recent volume spikes

2026-10-29: 9.3x the 50-day median, price +7.2% that day

2026-10-28: 7.2x the 50-day median, price -2.2% that day

2026-10-27: 15.1x the 50-day median, price +13.3% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

82.3xP/E todayNear its historic high
Against its own history83rd percentile
CheapestMedian 61.6xDearest

Usual range 48.2x to 98.0x since 2021-09.

Against Process Industries82.3x vs 18.1x
This company
82.3x
Sector median
18.1x

355% above the Process Industries median.

13.7x82.9x152.1x221.4xSep '21Oct '22Nov '23Dec '24Jan '26Nov '2613.7x82.9x152.1x221.4xSep '21Jun '23Mar '25Nov '26
P/E (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianProcess Industries median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianProcess Industries median
How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Process Industries is valued

Where does it rank among Process Industries peers?

Each cell is the company's percentile rank among its Process Industries peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

  • ROCE96th▲ 15 pts vs a year ago
  • Op. margin98th▲ 5 pts vs a year ago
  • Revenue growth91stflat vs a year ago
  • EPS growth87th▼ 10 pts vs a year ago
  • Debt/equity ↓88th▼ 4 pts vs a year ago
  • Cash cycle ↓34th▼ 7 pts vs a year ago
  • P/E ↓8thflat vs a year ago
  • 12M momentum97thflat vs a year ago

Rank history

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26
Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Process Industries sector page Watch it move against Process Industries in the Observatory

What is the price implying?

~46%annual earnings growth implied by the priceAbove delivered growth

At normalised P/E (five-year average earnings) of 221.2x, a holder earning 12%/yr needs earnings to grow about 46.1%/yr for 10 years, then trade at 15x.

Delivered34.7%/yrEPS, last 10 fiscal years · 3-yr avg to 3-yr avg
Gap+11.4 ptsimplied minus delivered
Rank294thmost demanding of 856

Over time

Implied growth by month (solid) and delivered growth (dashed).

0%25%51% Sep 2021Nov 2026 0%25%51% Sep 2021Nov 2026

Change the assumptions

Exit P/E / return11%12%13%
12x48.0%49.3%50.6%
15x44.8%46.1%47.4%
20x40.8%42.0%43.3%

Drag a slider to test other assumptions

Implied: 46.1%/yr

Looking back

  • Jan 2022Price implied 38%/yr; EPS has since grown 39%/yr (5.0 yrs)

Past comparisons cover only companies listed today (survivorship bias) and say nothing about future outcomes.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect. How this is calculated and the market-wide lists.

What prices imply across Process Industries The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov
₹3882.60
P/E
82.3x
ROCE
32.0%
Market Cap
₹31784 cr
Revenue (TTM)
₹1462 cr
P/S
21.7x
P/B
19.2x
ROE
23.3%
Operating Margin
34.0%
Debt / Equity
0.0x
Promoter Holding
32.7%
12M Momentum
111.3%

52-week range

₹1570.00₹4045.30
93% of the way from its 52-week low to its high

Price risk

1Y volatility
47.1%
Beta vs sector
1-year daily
0.65

Balance sheet & cash

Interest cover
operating profit ÷ interest
100.0x
Cash from profit, 3Y
operating cash flow ÷ net profit
0.95x
Share count, 1Y
unchanged

Are profits backed by cash?

6 of 7checks within range1 beyond a threshold
Other income reliance5%Within range

Other income as a share of pre-tax profit (trailing twelve months): 5.3%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate26%Within range

Median quarterly effective tax rate over about 2.5 years: 26.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion0.95xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 0.95x (cash from operations ₹535 cr, net profit ₹565 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow0 of 5 yrsBeyond threshold

Fiscal years with positive free cash flow in the last 5: 0. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history-6 daysWithin range

Debtor days are below the median of the previous three fiscal years by 6 days (99 vs 105). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress45% of fixed assetsWithin range

Capital work-in-progress is 45% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days-20 days / 2 yrsWithin range

Days payable changed by -20 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 2 years, DIIs added 12.0 pts; FIIs added 9.9 pts; promoters trimmed 7.2 pts.
  • The number of shareholders rose from 83,344 to 1.3 lakh (+51%) between Dec 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupDec '23Jun '26Change
Promoters39.9%32.7%-7.3 pts
FIIs11.7%21.6%+9.9 pts
DIIs7.6%19.6%+12.0 pts
Public and others40.9%26.2%-14.7 pts

Number of shareholders

1.3 lakhshareholders+51% since Dec '23
83k97k1.1L1.3L Dec '23Jun '24Dec '24Jun '25Dec '25Jun '26
Dec '23: 83,344
Mar '24: 95,784
Jun '24: 90,987
Sep '24: 93,394
Dec '24: 95,756
Mar '25: 1.1 lakh
Jun '25: 1.2 lakh
Sep '25: 1.1 lakh
Dec '25: 1.1 lakh
Mar '26: 1.1 lakh
Jun '26: 1.3 lakh
 83k97k1.1L1.3L Dec '23Dec '24Dec '25Jun '26
Dec '23: 83,344
Mar '24: 95,784
Jun '24: 90,987
Sep '24: 93,394
Dec '24: 95,756
Mar '25: 1.1 lakh
Jun '25: 1.2 lakh
Sep '25: 1.1 lakh
Dec '25: 1.1 lakh
Mar '26: 1.1 lakh
Jun '26: 1.3 lakh

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−3.5%typical 12-month return vs the marketNot meaningfully different from the base rate
  • We found 50 past situations where a non-financial company looked like ACUTAAS CHEMICALS LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −27% to +15% vs the market, against −2% for all non-financial companies in the same months.
  • The gap against the base rate (−1.5%, 80% range −17.5% to +3.6%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

−100%−50%0%+50%+100%
NEWGEN · Dec 2024: −53.0% vs market
VAIBHAVGBL · Feb 2021: −51.3% vs market
ZENTEC · Dec 2024: −47.0% vs market
IEX · Nov 2021: −45.5% vs market
POLYMED · Apr 2025: −44.9% vs market
OFSS · Dec 2024: −41.2% vs market
FINEORG · Sep 2022: −40.8% vs market
THYROCARE · Oct 2020: −37.9% vs market
ASTRAZEN · Jun 2020: −37.7% vs market
KFINTECH · Dec 2024: −33.3% vs market
CAMS · Dec 2024: −30.9% vs market
ADVENZYMES · Sep 2020: −28.1% vs market
CDSL · Jun 2025: −27.4% vs market
IGL · Mar 2020: −26.5% vs market
INDIAMART · Dec 2020: −25.1% vs market
RHIM · Dec 2022: −24.5% vs market
DHANUKA · Jul 2020: −23.5% vs market
LINDEINDIA · Aug 2023: −21.7% vs market
FCL · Sep 2022: −21.6% vs market
ASTRAL · Jun 2021: −16.8% vs market
ACE · Mar 2024: −15.0% vs market
NETWEB · Aug 2024: −12.0% vs market
GRINDWELL · Dec 2021: −10.3% vs market
AJANTPHARM · Jul 2020: −10.2% vs market
GMMPFAUDLR · Mar 2020: −4.7% vs market
INGERRAND · Apr 2023: −2.2% vs market
NAVINFLUOR · Nov 2020: −1.3% vs market
NEULANDLAB · Nov 2024: −0.4% vs market
BLS · Aug 2023: −0.4% vs market
HONAUT · Mar 2020: +2.0% vs market
LALPATHLAB · Feb 2020: +3.8% vs market
TRITURBINE · Jun 2023: +4.1% vs market
METROPOLIS · May 2020: +7.1% vs market
JUBLFOOD · May 2020: +7.9% vs market
EMUDHRA · Mar 2024: +8.7% vs market
PIIND · Jan 2020: +8.9% vs market
AFFLE · Sep 2020: +13.6% vs market
PERSISTENT · Jun 2021: +15.7% vs market
TIPSMUSIC · Feb 2024: +18.9% vs market
BDL · Mar 2023: +19.3% vs market
DATAPATTNS · Apr 2023: +20.9% vs market
HINDCOPPER · Oct 2025: +24.5% vs market
ALKYLAMINE · Nov 2020: +40.7% vs market
BSE · Jan 2025: +49.1% vs market
COFORGE · Jul 2020: +68.6% vs market
MCX · Oct 2025: +82.3% vs market
TDPOWERSYS · Oct 2025: +94.7% vs market
MAZDOCK · May 2024: +107.9% vs market
RPEL · Oct 2025: +125.2% vs market
ATGL · Feb 2021: +158.4% vs market
Similar setups −3.5%All companies −2.0%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 3 beyond the range shown, drawn at the edge

Similar setups' median
−3.5%
All companies' median
−2.0%
Beat the market
42% vs 48%

50 past situations · 50 companies · 30 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
KFINTECH
Technology Services		 Dec 2024 88x30% +219%−4% −33%
ASTRAZEN
Health Technology		 Jun 2020 123x34% +67%−2% −38%
FINEORG
Process Industries		 Sep 2022 82x39% +127%−3% −41%
THYROCARE
Health Services		 Oct 2020 69x35% +102%−5% −38%
NEWGEN
Technology Services		 Dec 2024 82x27% +118%0% −53%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
TRITURBINE
Producer Manufacturing		 Jun 2023 67x29% +160%−4% +4%
GMMPFAUDLR
Producer Manufacturing		 Mar 2020 73x29% +108%−25% −5%
HONAUT
Electronic Technology		 Mar 2020 64x35% +16%−32% +2%
How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: drawdown from 12-month high, size and debt/equity. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 5 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to ACUTAAS CHEMICALS LIMITED. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

DATA PATTERNS INDIADATAPATTNS
Electronic Technology
76%similar
P/Emarket cap
TD POWER SYSTEMSTDPOWERSYS
Producer Manufacturing
71%similar
revenue growthROCE
MULTI COMMODITY EXCHANGEMCX
Finance
68%similar
EPS growthmarket cap
CUPIDCUPID
Consumer Non-Durables
64%similar
ROCEEPS growth
NEULAND LABORATORIESNEULANDLAB
Health Technology
63%similar
promoter holdingoperating margin
SHAILY ENGINEERING PLASTICS LTSHAILY
Process Industries
68%similar
P/EEPS growth
GARWARE HI TECH FILMSGRWRHITECH
Process Industries
50%similar
market capoperating margin
NAVIN FLUORINE INTERNATIONAL LNAVINFLUOR
Process Industries
45%similar
operating marginmarket cap

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

30 events since Jan '24

  1. OctPriceVolume reached 15.1x its 50-day median on 2026-10-27; price +13.3% that day.
  2. AprPriceVolume reached 7.5x its 50-day median on 2026-04-30; price +3.7% that day.
  3. JanDebtDebt / equity halved over 12 months to 0.01x.
  4. JanPriceVolume reached 5.8x its 50-day median on 2026-01-28; price +7.8% that day.
  5. DecInstitutionsFII + DII holding rose 4.6 pts over 2 quarters to 39.4%.
  6. NovPriceVolume reached 8.8x its 50-day median on 2025-11-24; price +10.0% that day.
  7. SepPromoterPromoter holding fell 3.3 pts to 32.7% (largest drop since 2024-09).
  8. JulPriceVolume reached 7.3x its 50-day median on 2025-07-31; price +8.8% that day.
Show 22 earlier events
  1. JunPeer rankMoved into the top quartile of Process Industries on ROCE (from the 2nd quartile).
  2. JunDebtDebt / equity halved over 12 months to 0.01x.
  3. JunDividendDividend payout cut from 26% to 8% of profit.
  4. JunSharesShare count is up 10.8% over 12 months.
  5. MayPriceVolume reached 5.7x its 50-day median on 2025-05-02; price +2.8% that day.
  6. MarInstitutionsFII + DII holding rose 8.0 pts over 2 quarters to 35.8%.
  7. MarPeer rankMoved into the top quartile of Process Industries on EPS growth (from the 2nd quartile).
  8. JanPriceVolume reached 14.7x its 50-day median on 2025-01-29; price +20.0% that day.
  9. DecResultsYear-on-year EPS growth turned positive.
  10. DecPeer rankMoved into the 2nd quartile of Process Industries on EPS growth (from the bottom quartile).
  11. OctPriceVolume reached 10.9x its 50-day median on 2024-10-29; price +13.0% that day.
  12. SepPromoterPromoter holding fell 3.9 pts to 36.0%.
  13. SepPeer rankSlipped to the bottom quartile of Process Industries on EPS growth (from the 3rd quartile).
  14. SepPriceVolume reached 6.0x its 50-day median on 2024-09-13; price +3.4% that day.
  15. JulPriceRegained the 2021-10 peak, 29 months after the low.
  16. JunResultsYear-on-year EPS growth turned negative.
  17. JunInstitutionsFII + DII holding fell 3.5 pts over 1 quarter to 15.8%.
  18. JunValuationP/E crossed above the 90th percentile of its own history to date (111.4x).
  19. JunPeer rankSlipped to the 3rd quartile of Process Industries on EPS growth (from the 2nd quartile).
  20. JunPriceVolume reached 11.7x its 50-day median on 2024-06-19; price +4.5% that day.
  21. AprPeer rankSlipped to the 2nd quartile of Process Industries on ROCE (from the top quartile).
  22. JanPriceVolume reached 9.1x its 50-day median on 2024-01-29; price +5.4% that day.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history63 months · 2021-09 to 2026-11
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-1182.3x₹1462 cr23.3%32.0%0.0x
2026-1084.9x₹1462 cr23.4%32.0%0.0x
2026-0969.5x₹1462 cr23.4%32.0%0.0x
2026-0872.6x₹1339 cr21.5%32.0%0.0x
2026-0771.4x₹1339 cr21.5%32.0%0.0x
2026-0681.0x₹1339 cr21.5%32.0%0.0x
2026-0589.4x₹1214 cr21.8%20.0%0.0x
2026-0474.0x₹1214 cr21.8%20.0%0.0x
2026-0373.0x₹1214 cr21.8%20.0%0.0x
2026-0278.9x₹1096 cr17.1%20.0%0.0x
2026-0169.9x₹1096 cr17.1%20.0%0.0x
2025-1262.3x₹1096 cr17.1%20.0%0.0x
2025-1179.6x₹1037 cr14.5%20.0%0.0x
2025-1074.8x₹1037 cr14.5%20.0%0.0x
2025-0957.1x₹1037 cr14.5%20.0%0.0x
2025-0872.5x₹1007 cr12.3%20.0%0.0x
2025-0768.5x₹1007 cr12.3%20.0%0.0x
2025-0659.0x₹1007 cr12.3%20.0%0.0x
2025-0577.5x₹924 cr18.4%16.0%0.3x
2025-0474.5x₹924 cr18.4%16.0%0.3x
2025-0380.4x₹924 cr18.4%16.0%0.3x
2025-0290.7x₹815 cr14.4%16.0%0.3x
2025-0199.8x₹815 cr14.4%16.0%0.3x
2024-1289.9x₹815 cr14.4%16.0%0.3x
2024-11221.4x₹740 cr6.2%16.0%0.3x
2024-10204.3x₹740 cr6.2%16.0%0.3x
2024-09180.0x₹740 cr6.2%16.0%0.3x
2024-08119.1x₹717 cr7.3%16.0%0.3x
2024-07115.3x₹717 cr7.3%16.0%0.3x
2024-06111.4x₹717 cr7.3%16.0%0.3x
2024-0553.2x₹617 cr14.0%21.0%0.0x
2024-0453.8x₹617 cr14.0%21.0%0.0x
2024-0347.8x₹617 cr14.0%21.0%0.0x
2024-0248.8x₹617 cr14.0%21.0%0.0x
2024-0150.9x₹617 cr14.0%21.0%0.0x
2023-1249.1x₹617 cr14.0%21.0%0.0x
2023-1148.7x₹617 cr14.0%21.0%0.0x
2023-1051.2x₹617 cr14.0%21.0%0.0x
2023-0953.9x₹617 cr14.0%21.0%0.0x
2023-0857.6x₹617 cr14.0%21.0%0.0x
2023-0750.0x₹617 cr14.0%21.0%0.0x
2023-0655.7x₹617 cr14.0%21.0%0.0x
2023-0561.6x₹520 cr13.8%24.0%0.0x
2023-0454.0x₹520 cr13.8%24.0%0.0x
2023-0345.1x₹520 cr13.8%24.0%0.0x
2023-0246.0x₹520 cr13.8%24.0%0.0x
2023-0145.3x₹520 cr13.8%24.0%0.0x
2022-1248.9x₹520 cr13.8%24.0%0.0x
2022-1149.4x₹520 cr13.8%24.0%0.0x
2022-1048.1x₹520 cr13.8%24.0%0.0x
2022-0946.2x₹520 cr13.8%24.0%0.0x
2022-0850.3x₹520 cr13.8%24.0%0.0x
2022-0752.6x₹520 cr13.8%24.0%0.0x
2022-0644.5x₹520 cr13.8%24.0%0.0x
2022-0550.8x₹341 cr32.3%33.0%0.8x
2022-0466.2x₹341 cr32.3%33.0%0.8x
2022-0358.5x₹341 cr32.3%33.0%0.8x
2022-0250.7x₹341 cr32.3%33.0%0.8x
2022-0157.9x₹341 cr32.3%33.0%0.8x
2021-1262.3x₹341 cr32.3%33.0%0.8x
2021-1152.6x₹341 cr32.3%33.0%0.8x
2021-1059.8x₹341 cr32.3%33.0%0.8x
2021-0974.8x₹341 cr32.3%33.0%0.8x

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback